NCT04119102 Duobrii in Combination With Biologics
| NCT ID | NCT04119102 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Psoriasis Treatment Center of Central New Jersey |
| Condition | Psoriasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2019-10-14 |
| Primary Completion | 2020-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 25 participants in total. It began in 2019-10-14 with a primary completion date of 2020-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Eligibility Criteria
Inclusion Criteria: 1. Male or female adult ≥ 18 years of age; 2. Diagnosis of chronic plaque-type 3. Psoriasis affecting 2%-10% BSA 4. Patient is being treated with biologic therapy for a minimum of 24 weeks 5. Able and willing to give written informed consent prior to performance of any study-related procedures Exclusion Criteria: 1. Psoriasis affecting ˂2% or \>10% BSA 2. Patient not receiving a biologic agent, or receiving biologic agent \<24weeks 3. Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit. 4. Has previously used DUOBRII
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04119102 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psoriasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04119102 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT04119102 currently recruiting?
Yes, NCT04119102 is actively recruiting participants. Contact the research team at dreamacres1@aol.com for enrollment information.
Where is the NCT04119102 trial being conducted?
This trial is being conducted at East Windsor, United States.
Who is sponsoring the NCT04119102 clinical trial?
NCT04119102 is sponsored by Psoriasis Treatment Center of Central New Jersey. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.